{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-245807","form_type":"8-K","ticker":"BNTC","cik":"0001808898","company_name":"Benitec Biopharma Inc.","filed_at":"2023-09-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.343522+00:00","generated_at":"2026-06-10T07:44:04.887933+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Benitec Biopharma regains Nasdaq compliance with $28.6M equity offering","bullets":["Regained compliance with Nasdaq minimum stockholders' equity rule via $28.6M net proceeds from August 2023 offering.","As of June 30, 2023, stockholders' equity was below $2.5M requirement; offering resolved deficiency.","Offering included 875,949 common shares, 15,126,226 pre-funded warrants, and 16,002,175 common warrants at $1.93 per unit.","Nasdaq will continue to monitor compliance; non-compliance at next report could lead to delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-245807","json":"https://secwatch.observer/filing/0001193125-23-245807.json","markdown":"https://secwatch.observer/filing/0001193125-23-245807.md","text":"https://secwatch.observer/filing/0001193125-23-245807.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523245807/0001193125-23-245807-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523245807/d512438d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T07:44:04.887933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}